Lasa Supergenerics Share Price Lasa Supergeneri

42.40

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

42.05

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 10-Jun-2020 - -
Intimation about the Board Meeting and Closure of Trading Window
Board Meeting - 28-May-2020 - -
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2020 ,inter alia, to consider and approve Inter-alia, to consider, approve and take on record Audited Financial Results along with the Auditor Report of the Company for the quarter and year ended March 31, 2020, and/or to discuss any other business/matter with the permission of the Chair Further to our outcome of Board Meeting held on June 05, 2020 we are enclosing signed Audited Financial Results for the Quarter and Year ended March 31, 2020 along with Statement of Assets and Liabilities, Cash Flow statement & Audit Report for the year ended March 31, 2020. (As Per BSE Announcement dated on 10.06.2020)
Board Meeting - 18-Feb-2020 - -
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 30 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, Meeting of Board of Directors of the Company is Scheduled to be held on Saturday 22, 2020 at the corporate office of the company inter-aila to consider and approve scheme of amalgamation for absorption of a Harishree Aromatics and Chemicals Private Limited. In accordance with Companys Code of Conduct, the Trading Window of the company shall be closed till February 25, 2020. 1. Acquisition of Harishree Aromatics and Chemicals Private Limited through Scheme of Amalgamation. 2. Appointment of Merchant Bankers and other consultants to scheme. (As Per BSE Announcement Dated 22.02.2020)
Board Meeting - 01-Feb-2020 - -
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2020 ,inter alia, to consider and approve and take on record Unaudited Financial Results of the Company along with Limited Review Report for the quarter ended December 31, 2019 The Board of Directors in their meeting held today at the Corporate Office of the Company have considered, approved and took on record the Unaudited Financial Results for the quarter and nine months ended December 31,2019. (As Per BSE Announcement Dated on 10/02/2020)
Board Meeting - 04-Nov-2019 - -
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that a Meeting of the Board of Director of the Company is scheduled to be held on Tuesday, November 12, 2019 at 11.00 a.m. (IST) at the Corporate Office of the Company Inter-alia, to consider, approve and take on record Unaudited Financial Results of the Company along with Limited Review Report for the quarter / half year ended September 30, 2019, and/or to discuss any other business/matter with the permission of the Chairman. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Companys Code of Conduct, the Trading Window shall continue to remain closed till November 15, 2019. Pursuant to Regulation 29 and Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the meeting of Board of Directors of the company held today at the Corporate Office of the Company which was commenced at 11.00 a.m. and concluded at 4.30 p.m. have considered, approved and took on record the Unaudited Financial Results for the quarter and half year ended September 30, 2019. A copy of the statement of Unaudited Financial Results along with Limited Review Report submitted by the Statutory Auditors of the Company is attached herewith. (As Per BSE Announcement Dated 12.11.2019) Pursuant to Regulation 29 and Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the meeting of Board of Directors of the company held today at the Corporate Office of the Company which was commenced at 11.00 a.m. and concluded at 4.30 p.m. have considered, approved and took on record the Unaudited Financial Results for the quarter and half year ended September 30, 2019. (As Per BSE Announcement Dated 13.11.2019) Pursuant to Regulation 47 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, please find enclosed herewith copies of newspaper advertisements. (As per BSE Announcement Dated on 15.11.2019)
Board Meeting - 13-Aug-2019 - -
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/08/2019 ,inter alia, to consider and approve a)to decide the time, date and venue of 4th Annual General Meeting (AGM) Of The Company b)to approve Directors Report for the financial year 2018-19. c)to approve draft Notice of 4th Annual General Meeting of the Company d)to appoint scrutinizer for conducting e- voting at 4th Annual General Meeting of the company e)to consider issue of equity shares on preferential basis to Promoter in accordance with the existing applicable regulations of Securities Exchange Board of India. With reference to our earlier announcement dated August 13 2019 regarding the meeting of Board of Directors of the company which was scheduled to be held on Monday, August 19th 2019, stands postponed due to un-avoidable circumstance, rescheduled date of Board meeting of the same agenda shall be announced through separate intimation. (As Per BSE Announcement Dated on 17/08/2019) (As per BSE Bulletin dated on 26/08/2019) Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2019 ,inter alia, to consider and approve With reference to our earlier notice dated August 13, 2019 and August 17, 2019 we hereby inform you that Meeting of the Board of Directors of the Company is rescheduled on Thursday, August 29, 2019 at 11.00 a.m. (IST) at the Corporate Office address of the Company whereas the agenda remains unchanged. (As Per BSE Announcement Dated On 26/08/2019) Outcome of Board Meeting held today i.e. 29 August, 2019 The Board of Directors at its meeting held today inter-alia considered and approved the following; 1) venue, date and time of 4th Annual General Meeting of the Company. 2) notice of 4th Annual General Meeting along with Directors Report for the financial year 2018-19. 3) appointment of Mr. Amit R. Dadheech, Practicing Company Secretary to act as a Scrutinizer for 4th Annual General Meeting of the company. 4) approved preferential allotment of upto 1,78,08,219 equity shares of the company as per ICDR Regulations to Promoter of the company i.e Dr Omkar Herlekar for consideration other than cash subject to shareholders approval in the ensuing general meeting and statutory approvals (if any). (As Per BSE Announcement Dated 29.08.2019)
Board Meeting - 03-Aug-2019 - -
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2019 ,inter alia, to consider and approve and take on record Unaudited Financial Results of the Company along with Limited Review Report for the quarter ended June 30, 2019, and/or to discuss any other business/matter with the permission of the Chairman. Pursuant to Regulation 29 and Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we write to inform you that at the meeting held today at the Corporate Office of the Company which was commenced at 11.00 a.m. and concluded at 4.00 p.m. (As Per BSE Announcement Dated 12.08.2019)